Skip to main content
. 2017 Mar 30;11:1035–1041. doi: 10.2147/DDDT.S125743

Figure 1.

Figure 1

Mean GCSI severity scores at treatment initiation, 2 weeks, and 4 weeks after treatment with mirtazapine.

Note: The four variables with statistically significant 2 and 4 weeks changes (nausea, vomiting, retching, and loss of appetite) were included.

Abbreviation: GCSI, gastroparesis cardinal symptom index.